Review Article

Implications on the Therapeutic Potential of Statins via Modulation of Autophagy

Table 1

Modulation of autophagy by statins in different disorders.

Disease typeStatinTarget cell/diseaseConsequenceReference

CancerSimvastatinMotoneuron-like NSC34 cells, a model of neuroblastomaReduction of autophagic vacuoles and LC3II/I decreased cell survival[103]
SimvastatinBreast cancer cells of MDA-MB-231Inhibition of autophagy
Reduced survival of breast cancer cells
[86]
LovastatinMalignant mesothelioma ZL55 cancer cellsStimulation of autophagy
Reduced survival of malignant mesothelioma cells
[87]
LovastatinHuman malignant pleural mesothelioma ACC-MESO1 cellsInduction of autophagy
Decreased survival of malignant pleural mesothelioma
[120]
LovastatinHuman malignant peripheral nerve sheath tumor ST88-14 and NF90-8 cellsPerturbation of autophagy flux, induction of nonapoptotic cell death
Decreased survival of malignant peripheral nerve sheath tumor cells
[88]
AtorvastatinBreast cancer MDA-MB-231 cellsStimulation of autophagy
Inhibition of breast cancer cell proliferation
[92]
PitavastatinHuman melanoma WM115 and A375 cellsInduction of autophagy
Decreased survival of melanoma cells
[93]
RosuvastatinHuman papillary thyroid cancer cellsSuppression of autophagy
Induction of apoptosis in papillary thyroid cancer cells
[94]

OsteoarthritisSimvastatinMouse model of OAStimulation of autophagy
Deceleration of OA progression
[97]

Cardiovascular diseasesPitavastatinCardiomyocyteSuppression of autophagy
Decreased cardiomyocyte injury
[109]
SimvastatinMale Sprague-Dawley ratSuppression of autophagy
Decreased cardiomyocyte injury
[111]
AtorvastatinMouse model of atherosclerosisStimulation of autophagy
Suppression of inflammation
Increased stability of vulnerable atherosclerotic plaques
[108]
RosuvastatinMyocardial infarction model ratInduction of autophagy
Improved acute myocardial infarction
[110]

Neurodegenerative diseasesRosuvastatinRotenone-induced neurotoxicity model, PD SH-SY5Y cellsInduction of autophagy
Neuroprotective function against PD
[105]
Atorvastatin, pitavastatin, fluvastatin, pravastatin, simvastatin, and rosuvastatinIn vitro model of lipopolysaccharide- (LPS-) induced neuroinflammationSuppression of autophagy
Neuroprotective function
[106]